The Oncology Institute, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2024 | 0 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2024 | 0 | -$0.08 | -$0.08 | -$0.08 |
The Oncology Institute, Inc. Earnings Date And Information
The Oncology Institute, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.17 earnings per share for the quarter, missing analysts' consensus estimates of $-0.1 by $0.07. The company had revenue of 98.58 M for the quarter and had revenue of 324.24 M for the year. The Oncology Institute, Inc. has generated $-1 earnings per share over the last year ($-0.92 diluted earnings per share) and currently has a price-to-earnings ratio of -0.36. The Oncology Institute, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
The Oncology Institute, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.10 | -$0.17 | -0.07 | $103.31 M | $98.58 M |
| 05/22/2024 | Q1 2024 | -$0.22 | $94.67 M | |||
| 05/22/2024 | Q4 2023 | -$0.21 | $85.79 M | |||
| 11/08/2023 | Q3 2023 | -$0.13 | -$0.24 | -0.11 | $74.66 M | $82.04 M |
| 08/09/2023 | Q2 2023 | -$0.23 | $73.80 M | $80.22 M | ||
| 05/10/2023 | Q1 2023 | -$0.41 | $76.19 M | |||
| 03/16/2023 | Q4 2022 | -$0.13 | $71.42 M | |||
| 11/09/2022 | Q3 2022 | -$0.16 | -$0.03 | 0.13 | $68.95 M | $64.98 M |
| 08/09/2022 | Q2 2022 | -$0.07 | $60.92 M | |||
| 05/10/2022 | Q1 2022 | $0.22 | $55.16 M | |||
| 03/11/2022 | Q4 2021 | -$0.15 | $52.30 M | |||
| 11/08/2021 | Q3 2021 | -$0.04 | $52.28 M | |||
| 08/16/2021 | Q2 2021 | $0.05 | $49.84 M | |||
| 05/28/2021 | Q1 2021 | -$0.02 | $48.58 M | |||
| 03/30/2021 | Q4 2020 | -$0.30 | $187.51 M | |||
| 11/13/2020 | Q3 2020 | -$0.08 | $47.25 M | |||
| 08/13/2020 | Q2 2020 | $0.02 | $47.28 M | |||
| 05/08/2020 | Q1 2020 | -$0.43 | $44.02 M | |||
| 12/30/2018 | Q4 2018 | -$0.03 | $37.36 M |
The Oncology Institute, Inc. Earnings: Frequently Asked Questions
-
When is The Oncology Institute, Inc.'s earnings date?
The Oncology Institute, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
How can I listen to The Oncology Institute, Inc.'s earnings conference call?
The conference call for The Oncology Institute, Inc.'s latest earnings report can be listened to online.
-
How can I read The Oncology Institute, Inc.'s conference call transcript?
The conference call transcript for The Oncology Institute, Inc.'s latest earnings report can be read online.
-
How much revenue does The Oncology Institute, Inc. generate each year?
The Oncology Institute, Inc. (:TOI) has a recorded annual revenue of $324.24 M.
-
How much profit does The Oncology Institute, Inc. generate each year?
The Oncology Institute, Inc. (:TOI) has a recorded net income of $324.24 M. The Oncology Institute, Inc. has generated $-0.92 earnings per share over the last four quarters.
-
What is The Oncology Institute, Inc.'s price-to-earnings ratio?
The Oncology Institute, Inc. (:TOI) has a price-to-earnings ratio of -0.36 and price/earnings-to-growth ratio is -0.02.
